Table 1

Patient population

CharacteristicsFrequency (%)
Age (years)61.4 (mean)
Gender, n (%)
 Female7 (35)
 Male13 (65)
Ethnicity, n (%)
 South Asian16 (80)
 Caribbean black3 (15)
 Inter-racial1 (5)
Body mass index (kg/m2)28.0 (mean) (normal 18.5–24.9)
Weight (kg)73.1
Systolic blood pressure (mm Hg)144 (normal <120)
Diastolic blood pressure (mm Hg)81 (normal <80)
Comorbidities, n (%)
 Prior myocardial infarction10 (50)
 Diabetes mellitus10 (50)
  Glycosylated haemoglobin (%)8.3 (mean) (normal <6)
  Fasting blood glucose (mg/dL)182 (normal <126)
 Hypertension13 (65)
 Dyslipidaemia16 (80)
 Chronic kidney disease0 (0)
 Cerebrovascular events1 (5)
 Chronic obstructive pulmonary disease0 (0)
 Peripheral artery disease0 (0)
Cardiovascular medications, n (%)
 Aspirin20 (100)
 Clopidogrel20 (100)
 ACE inhibitor, angiotensin receptor blocker, neprilysin inhibitor13 (65)
 Beta blocker13 (65)
 Statin18 (90)
 Mineralocorticoid receptor antagonist3 (15)
 Calcium channel blocker4 (20)
 Nitrates5 (25)
 Ivabradine4 (20)
 Trimetazidine7 (35)
Diabetic medications, n (%)
 Insulins5 (25)
Oral hypoglycaemics, n (%)
 Metformin3 (15)
 Sulfonylureas1 (5)
 Glucagon-like peptide-1 receptor agonists0 (0)
 Dipeptidyl peptidase-4 inhibitors0 (0)
 Sodium–glucose cotransporter-2 inhibitors1 (5)
Cardiovascular procedures, n (%)
 Percutaneous coronary intervention5 (25)
 Coronary artery bypass grafting3 (15)
PRUs, n (%)
 PRU >20812 (60)
 PRU <2088 (40)
ARUs, n (%)
 ARU >55015 (75)
 ARU <5505 (25)
Basic laboratory values
 Serum haemoglobin (g/dL)13.4 (normal 13.2–17.6)
 Serum creatinine (mg/dL)0.92 (normal 0.81–1.21)
 Serum triglycerides (mg/dL)178 (normal <150)
 Serum total cholesterol (mg/dL)214 (normal <170)
 Serum low-density lipoprotein (mg/dL)162 (normal <130)
 Serum high-density lipoprotein (mg/dL)37 (normal >50)
  • ARU, aspirin reaction unit; PRU, P2Y12 reaction unit.